Latest filing published 31 Mar 2023 for Rhythm Pharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
William T. Roberts: trading record in brief
All filings by William T. Roberts on record concern Rhythm Pharmaceuticals, Inc., in the capacity of senior executive. Between 29 March 2022 and 29 March 2023, the trades on record add up to 7 filings.
No open-market purchase appears, only 4 sales worth €75k. Outside the open market, there are 3 option exercises. So far in 2023, the count stands at no purchases and 3 sales.
Most recently, on 31 March 2023, the filings show an open-market sale worth €15k in Rhythm Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William T. Roberts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 sharesCommon StockSEC:0001104659-23-040415:0
- 969 shares@ US$27.51100.0% of flowCommon StockSEC:0001104659-23-022071:0
- 2,313 sharesCommon StockSEC:0001104659-23-019824:0
- 2,500 sharesCommon StockSEC:0001104659-22-041079:0
4 of 4 declarations
